| View |
|
DR-XY36753
|
MONTELUKAST (as sodium)
|
Myteka
|
10 mg
|
film coated tablet
|
-
|
Hilton Pharma (Pvt.) Ltd.
|
Pakistan
|
-
|
06 November 2019
|
19 September 2024
|
| View |
|
DR-XY36754
|
Levofloxacin (as Hemihydrate)
|
Levores
|
5mg/ mL (500mg/ 100mL)
|
Solution for IV Infusion
|
Antibacterial
|
PT NOVELL PHARMACEUTICAL LABORATORIES
|
Indonesia
|
Automatic Renewal
|
21 September 2021
|
05 October 2026
|
| View |
|
DR-XY36764
|
Levofloxacin (As Hemihdyrate)
|
Levflox
|
500 mg
|
Fim-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
19 September 2019
|
08 October 2024
|
| View |
|
DR-XY36767
|
Levofloxacin (as Hemihydrate)
|
Levflox
|
750 mg
|
Fim-Coated Tablet
|
Antibacterial (Fluroquinolone)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
10 July 2024
|
08 October 2029
|
| View |
|
DR-XY36769
|
10% Dextrose in Water
|
Fluidex 10
|
10g/ 100mL (10% w/v)
|
Solution For Iv Infusion
|
-
|
Otsuka Pharmaceutical India Private Limited
|
India
|
-
|
26 March 2020
|
12 October 2024
|
| View |
|
DR-XY36770
|
Dextrose In Water (5% )
|
Dextrosol 5
|
50mg/ Ml (5% w/v)
|
Solution For I.V. Infusion
|
-
|
Otsuka Pharmaceutical India Private Limited
|
India
|
-
|
19 September 2019
|
12 October 2024
|
| View |
|
DR-XY36771
|
5% Dextrose in 0.9% Sodium Chloride
|
Norsalin D
|
50mg/ 9 mg per mL (5%w/v / 0.9% w/v
|
Solution For Iv Infusion
|
-
|
Otsuka Pharmaceutical India Private Limited
|
India
|
-
|
21 April 2020
|
12 October 2024
|
| View |
|
DR-XY36772
|
0.9% Sodium Chloride
|
None
|
None
|
Solution For I.V. Infusion
|
-
|
Otsuka Pharmaceutical India Private Limited
|
India
|
-
|
14 October 2019
|
05 December 2024
|
| View |
|
DR-XY36773
|
Lactated Ringer'S Solution
|
Aarel
|
100mL (320mg, 600mg, 40mg, 27mg)
|
Solution For I.V. Infusion
|
-
|
Otsuka Pharmaceutical India Private Limited
|
India
|
-
|
19 August 2019
|
08 October 2024
|
| View |
|
DR-XY36778
|
Olmesartan Medoxomil
|
Alzor
|
40mg
|
Film-Coated Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
-
|
16 February 2022
|
12 October 2024
|
| View |
|
DR-XY36779
|
Olmesartan medoxomil
|
Alzor
|
20mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Ajanta Pharma Limited
|
India
|
Renewal
|
04 August 2024
|
12 October 2029
|
| View |
|
DR-XY36781
|
Rosuvastatin (As Calcium)
|
Rosuvaz
|
10 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
19 April 2021
|
05 April 2026
|
| View |
|
DR-XY36786
|
Tobramycin + Dexamethasone
|
Zytodex
|
3 mg/1 mg per mL
|
Ophthalmic Suspension (eye Drops)
|
-
|
The Schazoo Pharmaceutical Laboratories (Pvt) Ltd.
|
Pakistan
|
Automatic Renewal
|
17 September 2019
|
12 October 2024
|
| View |
|
DR-XY36799
|
Salbutamol (As Sulfate)
|
Rogivent
|
2mg/5mL
|
Syrup
|
-
|
La Croesus Pharma, Inc.
|
Philippines
|
-
|
30 September 2019
|
13 October 2024
|
| View |
|
DR-XY36800
|
Sulfinpyrazone
|
Sulfin
|
100 mg
|
Tablet
|
Uricosuric
|
TTY Biopharm Company Limited Lioudu Factory
|
Taiwan
|
Automatic Renewal
|
19 July 2023
|
14 October 2028
|
| View |
|
DR-XY36801
|
Lactated Ringer's Solution
|
NIR-RL
|
(see reverse)
|
Solution for I.V. Infusion
|
Electrolyte Replenisher
|
Aculife Healthcare Private Limited
|
India
|
Automatic Renewal
|
03 November 2021
|
14 October 2026
|
| View |
|
DR-XY36803
|
5% Dextrose in 0.9% Sodium Chloride
|
NIR-DNS
|
Each 100 mL contains Glucose as anhydrous 5 g Sodium Chloride 900 mg Water for Injection qs
|
Solution for Intravenous Infusion
|
REHYDRATION SOLUTION
|
Aculife Healthcare Pvt. Ltd.
|
India
|
Automatic Renewal
|
29 March 2022
|
24 May 2027
|
| View |
|
DR-XY36827
|
Mometasone Furoate
|
Mosone
|
1 mg/g (0.1 %)
|
Topical Cream
|
-
|
Helviina Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
17 September 2019
|
16 October 2024
|
| View |
|
DR-XY36829
|
Cefazolin (as Sodium)
|
Fazonil
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
-
|
19 December 2019
|
12 January 2025
|
| View |
|
DR-XY36833
|
Hydrocortisone (as sodium succinate)
|
Hydrovex
|
100mg
|
Powder For Injection (IM/IV)
|
Corticosteroid
|
Shandong Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
19 May 2024
|
19 October 2029
|